KARYOPHARM THERAPE financial statements, including revenue, expenses, profit, and loss

The total revenue of 25K for the last quarter is 38.47 M CHF, and it's 28.72% higher compared to the previous quarter. The net income of Q2 24 is 21.39 M CHF.